Pharmaceuticals, Biotechnology and Life Sciences
Added Additional Treatment Arm and Provided Enrollment Update for Ongoing ELX-02 Phase 2 Clinical Trials for Cystic Fibrosis (CF) Nominated…
Announced first patient dosed in Phase 1 trial evaluating KIN-2787 in patients with BRAF mutation-positive solid tumors Strengthened management team and…
Acumen’s investigational drug, ACU193, is the first humanized monoclonal antibody discovered and developed to selectively target toxic amyloid-beta oligomers (AβOs)…
Nes Ziona, Israel, Aug. 15, 2021 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming…
CALGARY, Alberta, Aug. 13, 2021 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a…
PARIS and CAMBRIDGE, Mass., Aug. 13, 2021 (GLOBE NEWSWIRE) — Biophytis SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or…
BOSTON and JERUSALEM, Aug. 13, 2021 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of…
Company announcement No. 51 / 2021 Employee Elected Director to step down from the board of Zealand Pharma A/S Copenhagen,…
RENO, NV, Aug. 13, 2021 (GLOBE NEWSWIRE) — XcelPlus International Inc. (OTC PINK: XLPID) announced today that it intends to actively…
SAN JOSE, Calif., Aug. 13, 2021 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (Nasdaq:RANI) (“Rani Therapeutics” or “Rani”), a clinical…